Patrick Johnson is the CEO of BioPhotas, Inc., and the inventor of the award-winning Celluma series of light therapy devices. He has served as a senior executive in medical device companies, both public and private, for more than 20 years. Considered an authority on the science of light therapy, his expertise is sought after worldwide. For more information about Celluma, visit www.celluma.com.
Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Research supports the effectiveness of selecting the distal acupuncture points for the treatment of microtrauma and for relieving pain, particularly in cases of chronic shoulder pain. But to make the treatment results long-lasting, clinical experience and research suggest that instead of treating the most painful structure first, we identify the inhibited driver, restore reliable recruitment, confirm it with immediate re-testing, and only then address the painful area as a branch of a deeper pattern.
| Digital Exclusive
The motivation behind our practice of medicine is important, impacting not just our experience but also the experiences of those we treat. It is perhaps for this reason that the aspiration to help not just some, but all beings heal, has historically been an important part of the medical tradition. To explain this, we need to consider how medicine is interwoven with other social domains.